More recently, Zekavat et al. (71) have demonstrated that somatic mutations in blood mediated by the p53 gene lead to clonal hemopoiesis of indeterminate potential (CHIP), a preconceived normal aging process, and increase the risk of both CAD and PAD. This evidence concerns the gene TP53 and peripheral arterial disease.